TDI Preejection Velocities and Myocardial Viability
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00231205|
Recruitment Status : Unknown
Verified September 2005 by Charles University, Czech Republic.
Recruitment status was: Recruiting
First Posted : October 4, 2005
Last Update Posted : October 4, 2005
The purpose of the study is to test accuracy of positive preejection velocity to predict left ventricular remodeling and long-term prognosis after revascularization in 200 patients with chronically dysfunctional myocardium. Patients will be followed for 3 years.
Our hypothesis is that tissue-Doppler-derived analysis of positive preejection velocity allows to select optimal responders to revascularization; it means individuals with the greatest benefit in terms of LV remodeling and long-term prognosis.
|Condition or disease||Intervention/treatment|
|Coronary Artery Disease||Procedure: Revascularization|
|Study Type :||Observational|
|Enrollment :||200 participants|
|Observational Model:||Case Control|
|Observational Model:||Natural History|
|Official Title:||TDI-Derived Myocardial Preejection Velocities in Patients With Chronic Ischemic Left Ventricular Dysfunction Undergoing Surgical Revascularization|
|Study Start Date :||January 2005|
|Study Completion Date :||December 2009|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00231205
|Contact: Martin Penicka, MD, PhD||+420 26716 email@example.com|
|Contact: Petr Tousek, MD||+420 26716 firstname.lastname@example.org|
|III. Internal-cardiological clinic, 3rd Medical Faculty, Charles University||Recruiting|
|Prague, Czech Republic, 100 00|
|Contact: Martin Penicka, MD, PhD +420 26716 2724 email@example.com|
|Contact: Petr Tousek, MD +420 26716 2724 firstname.lastname@example.org|
|Principal Investigator: Martin Penicka, MD, PhD|
|Principal Investigator:||Martin Penicka, MD, PhD||Charles University, Prague, Czech Republic|